Get started
Author

Palma Pugliese

Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study
1997 · E. Bobbio-Pallavicini, C. Porta, et al. · European Journal of Cancer · 58
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
2022 · Lucia Del Mastro, Francesca Poggio, et al. · The Lancet Oncology · 55
Nipple sparing mastectomy with immediate breast reconstruction: a short term analysis of our experience.
2006 · A Psaila, M Pozzi, et al. · PubMed · 38
Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis
2006 · D. Fagnani, R. Franchi, et al. · Annals of Oncology · 29
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer.
2000 · A Riccardi, C Tinelli, et al. · International Journal of Oncology · 29
Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients
2000 · C Garufi, S Brienza, et al. · Anti-Cancer Drugs · 23
Nerve-sparing surgery in rectal cancer: feasibility and functional results.
2000 · R Mancini, M Cosimelli, et al. · PubMed · 20
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study
2024 · Chiara Molinelli, Marco Bruzzone, et al. · European Journal of Cancer · 16
PDF
Granulocyte Colony-stimulating Factors Used in Clinical Practice: PoloNord Registry-Based Cohort Italian Study
2014 · Daniele Fagnani, Luciano Isa, et al. · Tumori Journal · 16
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy
2010 · Laura Doni, Alessandra Perin, et al. · Critical Reviews in Oncology/Hematology · 16
Colon Cancer in Pregnancy: Report of a Case and Review of the Literature
2000 · Laura Balloni, Palma Pugliese, et al. · Tumori Journal · 16
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study
2020 · Alberto Zambelli, Edda Simoncini, et al. · The Breast · 15
PDF
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy: an echocardiographic study.
2000 · L Balloni, C Porta, et al. · Oncology Reports · 14
Quality of life and chronotherapy
2002 · P. Pugliese, C. Garufi, et al. · Chronobiology International · 9
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: A phase II study
2001 · S. Brugnatelli, A. Riccardi, et al. · Oncology Reports · 9
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)
2001 · A Riccardi, P Pugliese, et al. · British Journal of Cancer · 8
PDF
Increased Cortisol Secretion, Immune Activation and Mood Changes in Breast Cancer Patients Following Surgery and Adjuvant Chemotherapy
2015 · F. Cirulli, S. Capoccia, et al. · European Psychiatry · 7
Circulating progenitor cell release and functional characterization after topotecan plus G-CSF and erythropoietin in small cell lung cancer patients.
1999 · S Ferrari, M Danova, et al. · International Journal of Oncology · 7
Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer.
2000 · P Pugliese, M Danova, et al. · PubMed · 6
Weekly Docetaxel and Gemcitabine following Docetaxel plus Epirubicin or Vinorelbine as First-Line Treatment of Metastatic Breast Cancer: Results of a Multicenter Phase II Study
2006 · Alberto Riccardi, Silvia Brugnatelli, et al. · Tumori Journal · 5
Cell-mediated immune response in patients with type IIa, type IIb and type IV primary hyperlipoproteinaemia.
1988 · S Antonaci, E Jirillo, et al. · PubMed · 5
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer
2024 · Linda Cucciniello, Eva Blondeaux, et al. · npj Breast Cancer · 4
PDF
Trends in the choice of first line treatment for hormone - responsive (HR+), human epidermal growth factor receptor - 2 negative (HER2-) metastatic breast cancer (MBC) patients (pts): Results of a multicentric Italian observational study.
2018 · Alessia D'Alonzo, Claudia Bighin, et al. · Journal of Clinical Oncology · 3
Myeloprotective Effect of Early Primary Granulocyte-Colony Stimulating Factor during Six Courses of Intensified 5-Fluorouracil, Epirubicin and Cyclophosphamide (120FEC) Chemotherapy for Advanced Breast Cancer
1998 · Alberto Riccardi, Silvia Brugnatelli, et al. · Tumori Journal · 3
Paclitaxel in anthracycline-treated breast cancer patients.
1998 · P Pugliese, S Brugnatelli, et al. · Oncology Reports · 3
Works count: 46
Citation count: 425
H-index: 13
I10-index: 13
Year
Topic
Type